We are live on ! Find out more
EBS icon

Emergent Biosolutions

172 hedge funds and large institutions have $875M invested in Emergent Biosolutions in 2015 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 76 increasing their positions, 55 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more call options, than puts

Call options by funds: $325K | Put options by funds: $190K

43% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 14

38% more repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 55

7% more capital invested

Capital invested by funds: $818M → $875M (+$57.1M)

3% more funds holding

Funds holding: 167172 (+5)

0.34% more ownership

Funds ownership: 80.44%80.77% (+0.34%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
172
Holders Change
+5
Holders Change %
+2.99%
% of All Funds
4.58%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
20
Increased
76
Reduced
55
Closed
14
Calls
$325K
Puts
$190K
Net Calls
+$135K
Net Calls Change
+$130K
Name Holding Trade Value Shares
Change
Change in
Stake
TCIM
51
TIAA CREF Investment Management
New York
$3.42M -$20.1K -702 -0.6%
LSV Asset Management
52
LSV Asset Management
Illinois
$3.38M -$2.74M -95,409 -45%
CPIM
53
Columbia Partners Investment Management
Virginia
$3.19M +$3.18M +110,771 New
First Trust Advisors
54
First Trust Advisors
Illinois
$3.14M +$1.78M +62,169 +132%
Jacobs Levy Equity Management
55
Jacobs Levy Equity Management
New Jersey
$3.12M -$310K -10,800 -9%
BIM
56
BlackRock Investment Management
Delaware
$3.08M +$36.2K +1,261 +1%
GPP
57
Great Point Partners
Connecticut
$2.96M -$4.22M -147,209 -59%
CAM
58
ClariVest Asset Management
California
$2.78M -$32.3K -1,126 -1%
Deutsche Bank
59
Deutsche Bank
Germany
$2.77M +$351K +12,233 +15%
BA
60
BlackRock Advisors
Delaware
$2.77M +$32.6K +1,136 +1%
OAM
61
Oxford Asset Management
United Kingdom
$2.67M +$2.17M +75,497 +431%
GC
62
Globeflex Capital
California
$2.56M -$139K -4,840 -5%
MAA
63
Managed Account Advisors
New Jersey
$2.53M +$258K +9,001 +11%
NFA
64
Nationwide Fund Advisors
Ohio
$2.52M -$124K -4,313 -5%
ERSOT
65
Employees Retirement System of Texas
Texas
$2.24M
Comerica Bank
66
Comerica Bank
Texas
$2.24M -$2.23M -77,833 -50%
California Public Employees Retirement System
67
California Public Employees Retirement System
California
$2.24M
New York State Common Retirement Fund
68
New York State Common Retirement Fund
New York
$2.21M +$462K +16,107 +26%
MCM
69
Matarin Capital Management
New York
$2.17M -$206K -7,172 -9%
TI
70
Turner Investments
Pennsylvania
$2.07M -$780K -27,200 -27%
Prudential Financial
71
Prudential Financial
New Jersey
$1.91M +$31.5K +1,100 +2%
VOYA Investment Management
72
VOYA Investment Management
Georgia
$1.84M -$949K -33,096 -34%
SDIC
73
South Dakota Investment Council
South Dakota
$1.63M
Public Sector Pension Investment Board (PSP Investments)
74
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.61M +$30.3K +1,058 +2%
GKIM
75
GW&K Investment Management
Massachusetts
$1.58M +$414K +14,430 +35%

EBS Hedge Fund Activity: Q1 2015 in Review

172 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Emergent Biosolutions (EBS) for Q1 2015, worth a combined $875M — up 7% from $818M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new EBS positions and 14 closed out — a net gain of 6 holders — while 76 added to existing stakes and 55 trimmed.

The largest buyer was Numeric Investors, opening a new position worth an estimated $8.66M. The largest seller was Kingdon Capital Management, cutting an estimated $7.51M.

  • 172 institutional investors held Emergent Biosolutions (EBS) as of Q1 2015, up from 167 in Q4 2014.
  • Funds reported $875M of Emergent Biosolutions stock for Q1 2015, up 7% quarter-over-quarter.
  • 20 funds opened new Emergent Biosolutions positions in Q1 2015 and 14 closed out, a net change of +6 holders.
  • The largest Emergent Biosolutions buyer in Q1 2015 was Numeric Investors, an estimated $8.66M added.
  • The largest Emergent Biosolutions seller in Q1 2015 was Kingdon Capital Management, an estimated $7.51M sold.

Based on aggregated 13F filings for Q1 2015.